383 related articles for article (PubMed ID: 16044436)
1. Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: retrospective analysis of 21 cases.
Chen YC; Chou JM; Letendre L; Li CY
Am J Hematol; 2005 Aug; 79(4):329-31. PubMed ID: 16044436
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
Breccia M; Latagliata R; Mengarelli A; Biondo F; Mandelli F; Alimena G
Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
5. Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia.
Chen YC; Chou JM; Ketterling RP; Letendre L; Li CY
Am J Clin Pathol; 2003 Dec; 120(6):874-81. PubMed ID: 14671976
[TBL] [Abstract][Full Text] [Related]
6. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of micromegakaryocytes in de novo AML].
Kobayashi S; Seki K; Katayama N; Akiba C; Yamamoto T; Sakai K; Yamaguchi M; Maruta A; Noguchi T; Ogawa K
Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia.
Ngo NT; Lampert IA; Naresh KN
Br J Haematol; 2008 Jun; 141(6):771-81. PubMed ID: 18371110
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two new classifications for pediatric myelodysplastic and myeloproliferative disorders.
Occhipinti E; Correa H; Yu L; Craver R
Pediatr Blood Cancer; 2005 Mar; 44(3):240-4. PubMed ID: 15368549
[TBL] [Abstract][Full Text] [Related]
11. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
[TBL] [Abstract][Full Text] [Related]
12. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.
Kaiserling E; Horny HP; Geerts ML; Schmid U
Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
14. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity.
Schmitt-Graeff A; Thiele J; Zuk I; Kvasnicka HM
Haematologica; 2002 Apr; 87(4):392-9. PubMed ID: 11940483
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
16. [Syndrome of abnormal chromatin clumping in leucocytes with a high fraction of bone marrow cells in S-phase and in vitro autonomous growth].
Vallejo C; García-Marcos MA; Del Cañizo MC; Orfao A; Almeida J; Escribano L; San Miguel JF; Ríos A
Med Clin (Barc); 1997 Sep; 109(9):340-2. PubMed ID: 9379766
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
Machherndl-Spandl S; Sega W; Bösmüller H; Germing U; Gruber Ch; Nachtkamp K; Reinecke P; Sperr WR; Wimazal F; Müllauer L; Sotlar K; Horny HP; Tüchler H; Valent P; Krieger O
Ann Hematol; 2014 Jan; 93(1):57-64. PubMed ID: 24241126
[TBL] [Abstract][Full Text] [Related]
18. [Chronic myelomonocytic leukemia].
Kalnberza GK; Rotsena AIa; Bondare DK; Teĭlane IIa; Grant KhIa
Ter Arkh; 1988; 60(11):120-3. PubMed ID: 3238562
[TBL] [Abstract][Full Text] [Related]
19. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.
Vasef MA; Murata-Collins JL; Alsabeh R; Medeiros LJ
Arch Pathol Lab Med; 1998 Jan; 122(1):77-83. PubMed ID: 9448022
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
